Advancing Clinical Innovation with OXON at 19CTSS May 21-22, 2025 | Munich OXON will support the summit showcasing expanded services and new developments in RWE. We are proud to participate as a Silver Sponsor and exhibitor at the 19th Clinical Trials Strategic Summit (CTSS), taking place in Munich on May 21–22, 2025. This year’s Clinical…
Read more
Explore Cutting-Edge Clinical Trials and RWE Solutions with OXON at COS 2025 April 3-4, 2025 | Barcelona OXON will support as an exhibitor, showcasing expanded services and new developments in RWE. Join OXON at booth E1 during the Annual Clinical Outsourcing Summit (COS 2025) on April 3rd and 4th in Barcelona. This event, themed “Driving…
Read more
‘Unlocking Success: Mastering your Real-World RMM Studies Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 13 March 2025 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Antoine Pariente Director of the Department of Public Health & of the BPH AHeaD team – University of…
Read more
‘Unlocking Success: Mastering your RWE Pregnancy Studies Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Wednesday, 12 February 2025 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Helen Dolk Professor of Epidemiology and Health Services Research at Ulster University. REGISTER HERE Real-world evidence (RWE) plays…
Read more
OXON Epidemiology at the 21st Global CVCT Forum December 9-11, 2024 | Washington, DC OXON Epidemiology will be participating in the 21st Global CardioVascular Clinical Trialists Forum (CVCT), taking place in Washington, DC, from December 9 to December 11, 2024. This prestigious forum brings together global leaders in cardiovascular research, regulatory authorities, and industry experts…
Read more
OXON at CTS sharing a new method to boost trial and RWE study efficiency November 28-29, 2024 | Barcelona OXON will support CTS 2024 as an exhibitor, showcasing expanded services and new developments in RWE. OXON’s Epidemiology will be at the 9th Clinical Trial Summit in Barcelona to share how our Real-World Evidence (RWE)-driven clinical…
Read more
Evaluating ICDs’ Role in Reducing Sudden Cardiac Death Among High-Risk Patients OXON Epidemiology’s latest study, recently featured in JAMA Cardiology, provides critical insights into the effectiveness of implantable cardioverter-defibrillators (ICDs) compared to amiodarone in reducing sudden cardiac death among patients with chronic Chagas cardiomyopathy. Known as the CHAGASICS Randomized Clinical Trial, the study enrolled 323…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of Italy Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 24 October 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Carlo Giaquinto Professor of Paediatrics at the Department for Woman’s and Child’s Health of…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of France Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 19 September 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Patrick Blin Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific…
Read more
OXON’s new RWE services and developments at ISPE Annual Meeting August 24-28, 2024 | Estrel Congress Center | Berlin, Germany OXON will be supporting ICPE 2024 as an exhibitor, showcasing expanded services and new developments in RWE. We are excited to announce that OXON’s Epidemiology team will be presenting and exhibiting at the ISPE 2024…
Read more
